The Cultivated B (TCB) has entered into an MOU with The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark.
The collaboration aims to validate TCB’s bioreactor technology and establish new industry standards in bioprocessing, through enhancing the functionality and usability of TCB’s AUXO V bioreactors through thorough user testing and evaluation.
The companies expect the collaboration to make a substantial impact on advancing bioreactor technology, in turn improving scalability, efficiency and environmental sustainability in bioproduction processes.
TCB and DTU Biosustain will collaborate closely to incorporate user feedback from operational staff in the pilot facilities, PhD students, academic researchers and startups into their development processes.
DTU Biosustain researchers will serve as independent reviewers. Their role involves evaluating the performance of TCB’s bioreactors across different bioprocesses, collecting user feedback and validating the results against established market standards.
TCB’s main goal is to improve the user-friendliness and operational efficiency of its bioreactor technology by leveraging insights gained from practical user experiences.
Hamid Noori, CEO of The Cultivated B, said: “Our collaboration with DTU Biosustain reflects our dedication to pushing the boundaries of biotechnological innovation by focusing on tangible advancements and practical implementations of user feedback in the development cycle. Similar to software beta testing, by engaging with such an experienced team in this detailed evaluation and feedback loop, we can ensure that our bioreactors not only meet but anticipate and exceed the evolving needs of the user.”
CEO at DTU Biosustain, Bo Skjold Larsen, added: “We are looking forward to collaborating with The Cultivated B on taking its bioreactor technolology to the next level for the benefit of the centre’s research and for the whole biotechnology research and development community in general. Collaboration between academia and industry in bioreactor design and operation accelerates progress, fosters innovation and benefits society. It combines theoretical expertise with practical insights, driving efficiency, sustainability, and societal impact.”
